← Back to Search

CONNECT Intervention Group - Group A for Head and Neck Cancers (CONNECT-HNC Trial)

N/A
Waitlist Available
Led By Chandylen Nightingale, PhD, MPH
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

CONNECT-HNC Trial Summary

This trial will test a technology-based intervention to help caregivers of cancer patients understand and access supportive care resources.

Eligible Conditions
  • Head and Neck Cancer

CONNECT-HNC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability - (Intervention Arm Only)
Number of Eligible Participants
Number of Retention of Participants
+1 more
Other outcome measures
Barriers to Supportive Care Use Survey
Caregiver Adherence to Referral Survey
Caregiver Quality of Life Index-Cancer (CqoL-Canc)
+13 more

CONNECT-HNC Trial Design

2Treatment groups
Experimental Treatment
Group I: CONNECT Intervention Group - Group AExperimental Treatment1 Intervention
A web-based intervention (CONNECT) to empower and connect caregivers of newly diagnosed cancer patients to supportive care resources A randomized pilot study will be conducted to assess feasibility and acceptability and obtain data on caregiver and patient outcomes. CONNECT e-tool, re-education and optional referral (2 weeks post CONNECT e-tool). Baseline, one month post randomization data collection, three months post randomization data collection, quantitative and qualitative measures.
Group II: CONNECT Comparison Group - Group BExperimental Treatment1 Intervention
Baseline, one month post randomization data collection, three months post randomization data collection, quantitative and qualitative measures.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CONNECT
2016
N/A
~1330
CONTROL
2017
Completed Phase 4
~2100

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Science (NCATS)NIH
99 Previous Clinical Trials
36,269 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,243 Previous Clinical Trials
1,004,686 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
322 Previous Clinical Trials
401,723 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What benefits are anticipated to result from this research?

"This research study spans a period of 9 months and its primary objective is to assess acceptability. Secondary goals involve measuring the extent of emotional distress, caregiver reaction, and utilisation of supportive care through PROMIS Emotional Distress- Depression-Short Form 8a, Caregiver Reaction Assessment, and Supportive Care Utilization respectively."

Answered by AI

Are the enrollment criteria still in effect for this research trial?

"According to clinicaltrials.gov, this trial is not accepting new patients at present. The protocol was first published on September 16th 2020 and last amended on October 4th 2022. Nevertheless, 482 other trials are actively searching for participants of their own research projects."

Answered by AI
~9 spots leftby Apr 2025